UT Southwestern Medical Center has been selected as a Rare Disease Center of Excellence – charter members of an elite network of 31 centers nationally to expand access, and advance care and research for rare disease patients in the United States.

COVID-19 impairs the function of the body’s microvascular system with an intensity that corresponds to the severity of disease, suggests a new study by an international consortium, including UT Southwestern Medical Center.

Lorena Saelices Gomez, Ph.D., Assistant Professor of Biophysics and in the Center for Alzheimer’s and Neurodegenerative Diseases at UT Southwestern, has been awarded $1.5 million from the National Institutes of Health (NIH) to determine the structure of amyloids, key proteins that have been tied to

A study of patients resuscitated from out-of-hospital cardiac arrest shows that women have a lower likelihood of survival compared with men and are less likely to receive procedures commonly administered following cardiac arrest.

Eight scientists and physicians in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern have been awarded more than $11.5 million in grants from the Cancer Prevention and Research Institute of Texas (CPRIT) to support the state’s fight against cancer.

Three drugs that are already approved by the Food and Drug Administration (FDA) or other international agencies can block the production of the novel coronavirus that causes COVID-19 in human cells.

Researchers at UT Southwestern have uncovered evidence that the higher prevalence of “malignant” enlargement of the heart among blacks contributes to the higher incidence of heart failure in this population.

When William P. Clements Jr. University Hospital (CUH) opened on Dec. 6, 2014, it established a new level of care in North Texas, where patients could receive the most advanced treatments for both common and complex conditions in a truly healing environment.

The March 21 decision by NCCN to include the Simmons Cancer Center among its members recognizes Simmons Cancer Center’s elite status and will deepen its collaboration with national peers at the highest levels.

Researchers at the Kidney Cancer Program at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center have developed what could be the most complete catalog of clear cell renal cell carcinoma, the most common type of kidney cancer.